30 January 2024
Cambridge Cognition Holdings
plc
("Cambridge Cognition" or the
"Company")
Board
appointments
Cambridge Cognition Holdings plc
(AIM: COG), which develops and markets digital solutions to assess
brain health, is pleased to announce the appointment of Stuart Gall
and Philip Rodgers ("Nick") as independent non-executive Directors
of the Company, both with effect from 1 February
2024.
As announced in the Trading Update
this morning, the Company has seen revenue growth of 7% in 2023 and
an adjusted operating profit in the second half in a difficult
economic environment and is positioned to deliver further growth in
the future. The appointments will strengthen the Board to
support these growth plans by adding additional commercial,
investor relations and financial expertise. The additions to
the Board take the number of non-executive directors to five;
providing strengthened governance and succession for possible
future rotation of Board members.
Stuart Gall is CEO of Intelligent
Ultrasound, an AIM-listed medical imaging company providing one of
the world's leading 'classroom to clinic' ultrasound technologies.
Previous appointments include joint founder and executive director
of Fusion IP plc, an AIM listed university IP commercialisation
company, before its purchase by IP Group plc for £103 million in
2014. Stuart has over 30 years' experience in both small company
start-ups and public companies and previously worked at British
Airways plc, The Promotions Partnership Limited, Anvil Limited and
Toad plc (now Journeo plc).
Nick Rodgers is currently Chair of
SEHTA, one of the largest health technology membership and
networking organisations in the UK supporting businesses in the
health technology sector. Until 2023 Nick was Chair of Destiny
Pharma plc, a developer of novel anti-infective products and chair
of ZPN Energy Limited, a developer of battery storage technologies
and systems for the electric vehicle market. Previously, until
2016, Nick was chairman of Oxford BioMedica plc, a pioneer of gene
and cell therapy and a leader in lentiviral vector research,
development and bioprocessing.
Dr
Steven Powell, Chairman of Cambridge Cognition,
commented:
"On behalf of the Board, I am delighted to welcome Stuart and
Nick to Cambridge Cognition. Their broad expertise and deep
industry experience in the healthcare and technology sectors will
be extremely valuable in the next stage of Cambridge Cognition's
development now that we have integrated the two acquisitions made
in 2022/23, which strengthen the Company's product offering and
cement its leading market position. We look forward to
benefitting from their insights as the Board continues to lead
Cambridge Cognition to profitability and accelerate and execute the
Company's growth plans."
Further information:
The following details in relation to
the appointments of Stuart Gall and Nick Rodgers as directors of
the Company are disclosed in accordance with AIM Rule 17 and
Schedule 2(g) of the AIM Rules for companies:
Stuart Arthur Gall (aged 61 years)
holds or has held the following directorships or partnerships in
the last five years:
|
Current
|
Past 5 years
|
|
Intelligent Ultrasound
Limited
|
DEMASQ Limited
|
|
Intelligent Ultrasound Group
plc
|
I2LResearch Ltd
|
|
Medaphor International
Limited
|
|
|
Medaphor Limited
|
|
|
Inventive Medical Limited
|
|
|
IML Finance Ltd
|
|
|
Intelligent Ultrasound North America
Inc
|
|
Stuart was also a director of
Abcellute Limited and Abcellute Tissue Bank Limited at the time
that both companies entered into a creditors liquidation on 10
October 2012. Abcellute Limited was subsequently dissolved on 17
September 2016 and Abcellute Tissue Bank Limited was dissolved on
10 March 2016.
Philip Nicholas 'Nick' Rodgers (aged
65 years) holds or has held the following directorships or
partnerships in the last five years:
|
Current
|
Past 5 years
|
|
Science and Engineering Health
Technologies Alliance Limited
|
Alcuris Ltd
|
|
SEHTA Enterprises Limited
|
Destiny Pharma plc
|
|
Nick Rodgers Financial
Limited
|
Interactive Me Ltd
|
|
Productiv Limited
|
Powerme Leasing Ltd
|
|
|
Productiv Property
Limited
|
|
|
Productiv Technology
Limited
|
|
|
The Proving Factory
Limited
|
|
|
Zapme Limited
|
|
|
ZPN Energy Limited
|
Productiv Limited, a company which
Nick Rodgers is a director of, entered into a creditors voluntary
liquidation on 21 November 2022. The Company is currently still in
liquidation.
Save as disclosed above, there is no
further information to be disclosed in relation to appointments of
Stuart Gall or Nick Rodgers pursuant to AIM Rule 17 or Schedule
Two, paragraph (g) of the AIM Rules for Companies.
The information contained within this announcement is deemed
by the Company to constitute inside information stipulated under
the Market Abuse Regulation (EU) No. 596/2014 as it forms part of
UK domestic law by virtue of the European Union (Withdrawal) Act
2018. Upon the publication of this announcement via the
Regulatory Information Service, this inside information is now
considered to be in the public domain.
Enquiries
|
Cambridge Cognition Holdings plc
|
|
|
Matthew Stork, Chief Executive
Officer
Stephen Symonds, Chief Financial
Officer
|
Tel: 01223 810 700
press@camcog.com
|
|
|
|
|
Panmure Gordon (UK) Ltd (NOMAD and Joint
Broker)
Freddy Crossley / Emma Earl / Mark
Rodgers
Rupert Dearden
|
Tel: 020 78862500
(Corporate Advisory)
(Corporate Broking)
|
|
Dowgate Capital Limited (Joint
Broker)
David Poutney / James
Serjeant
|
Tel: 020 3903 7715
(Corporate Broking)
|
|
|
|
|
Hudson Sandler (Financial PR
and IR)
Dan de Belder / Hattie
Dreyfus
|
Tel: 020 7796 4133
cog@hudsonsandler.com
|
Notes to Editors
About Cambridge Cognition
Cambridge Cognition is a technology
company developing digital health products to better understand,
detect and treat conditions affecting brain health. The Company's
software products assess cognitive health in patients worldwide to
improve clinical trial outcomes, identify and stratify patients
early and improve global efficiency in pharmaceutical and
healthcare industries.
For further information visit
www.cambridgecognition.com